Renishaw: Precision-guided neurosurgery for life-enhancing therapies
Renishaw is a global leader in precision engineering technology. We apply our expertise to the challenges of functional neurosurgery, offering flexible solutions for robotic surgery and targeted drug delivery.
We base our neuromate stereotactic robot on our deep heritage of measurement expertise. Surgeons can use this platform to perform a variety of procedures with precision and accuracy. These include deep brain stimulation (DBS), Stereoelectroencephalography (SEEG), and intraparenchymal drug delivery.
The neuroinfuse drug delivery system offers comprehensive options for delivering medication directly to the brain. The system can be used to treat a variety of conditions, including Parkinson's disease, epilepsy, and brain tumours.
Our solutions align with current and emerging treatments, helping clinicians develop life-enhancing therapies that are safe and efficient.
Renishaw is applying precision engineering technology to the challenges of functional neurosurgery. Our aim is to help leading clinicians. We want to enhance the safety and cost-effectiveness of their procedures. This will result in improved patient outcomes due to the accurate delivery of implantable devices
We are proud of our reputation as a leader in the field of neurological products. We are dedicated to improving patient outcomes and delivering excellent customer service. Our advanced technology, tailored solutions, clinical evidence, global presence and customer support make us stand out from our competitors.